Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,190
-180 (-1.74%)
At close: Feb 25, 2026
Market Cap860.86B -1.0%
Revenue (ttm)1.03T +3.8%
Net Income56.45B -9.0%
EPS688.80 -26.7%
Shares Out84.48M
PE Ratio14.79
Forward PE22.75
Dividend100.00 (0.96%)
Ex-Dividend DateDec 29, 2025
Volume204,113
Average Volume356,869
Open10,370
Previous Close10,370
Day's Range10,170 - 10,430
52-Week Range7,680 - 10,800
Beta0.28
RSI59.85
Earnings DateJan 28, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,335
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.

Financial Statements